Disease Sciences is at it again, especially with last sentence:
>>Press Release
SOURCE: Disease Sciences, Inc.
Disease Sciences Announces 1 for 10 Reverse Split
BOCA RATON, Fla.--(BUSINESS WIRE)--Jan. 3, 2002--Disease Sciences, Inc. (OTC BB: DISE) announced today that it has declared a one for ten reverse stock split of its common stock, to be effective at the opening of trading on Monday, January 7, 2002. As a result of the reverse stock split, each ten shares of previously outstanding common stock will become one post-split share of common stock. Stockholders are not required to tender their existing certificates for shares, but may do so if they desire.
The new cusip number for the post-split shares of common stock will be 25469Y 20 5, and the new trading symbol for the common stock will be ``DSSC''. The number of common shares the company is authorized to issue, and the par value per share of the Company's common stock will not be effected by the reverse split.
Dr. Wayne Goldstein Disease Sciences CEO, stated, ``The re-capitalization of Disease Sciences is important to our future as it will allow the Company to expedite further funding to pay for its drug development program. Additionally, the re-capitalization may significantly enhance the possibility for the company to be acquired or to acquire other companies based upon its new structure.'' << |
